Login Register Cart 0
Generic placeholder image

Current Neuropharmacology

Editor-in-Chief

ISSN (Print): 1570-159X
ISSN (Online): 1875-6190

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets

Author(s): Tessa B. Johung and Michelle Monje

Volume 15, Issue 1, 2017

Page: [88 - 97] Pages: 10

DOI: 10.2174/1570159X14666160509123229

Price: $65

Abstract

Background: Diffuse Intrinsic Pontine Glioma (DIPG) is the leading cause of brain tumor-related death in children, with median survival of less than one year. Despite decades of clinical trials, there has been no improvement in prognosis since the introduction of radiotherapy over thirty years ago.

Objective: To review the clinical features and current treatment challenges of DIPG, and discuss emerging insights into the unique genomic and epigenomic mechanisms driving DIPG pathogenesis that present new opportunities for the identification of therapeutic targets.

Conclusion: In recent years, an increased availability of biopsy and rapid autopsy tissue samples for preclinical investigation has combined with the advent of new genomic and epigenomic profiling tools to yield remarkable advancements in our understanding of DIPG disease mechanisms. As well, a deeper understanding of the developmental context of DIPG is shedding light on therapeutic targets in the microenvironment of the childhood brain.

Keywords: Childhood cancer, Diffuse Intrinsic Pontine Glioma (DIPG), epigenetics, histone mutation, pediatric glioma, pediatric neurodevelopment.

« Previous
Graphical Abstract


Rights & Permissions Print Cite
Article Metrics
65
5
© 2024 Bentham Science Publishers | Privacy Policy